Telemonitoring of Patients With COPD in Carinthia
RenewingHealth
REgions of Europe WorkiNg toGether for HEALTH (Renewing Health)
1 other identifier
interventional
65
1 country
3
Brief Summary
Evaluation whether the introduction of large-scale telemonitoring of patients with COPD produces benefits in terms of reduced hospital readmissions, improved health related quality of life and health status. In addition, the trials evaluate the economical and organizational impact of the new services and examine their acceptability by patients and health professionals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2010
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2010
CompletedFirst Submitted
Initial submission to the registry
April 17, 2012
CompletedFirst Posted
Study publicly available on registry
April 18, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2014
CompletedResults Posted
Study results publicly available
July 1, 2015
CompletedJuly 23, 2015
April 1, 2015
3.4 years
April 17, 2012
April 8, 2015
July 1, 2015
Conditions
Outcome Measures
Primary Outcomes (2)
Health Related Quality of Life as Measured by the Short-Form 36 Version 2 Questionnaire; The Short Form (36) Health Survey is a 36-item, Patient-reported Survey of Patient Health. The SF-36 is a Measure of Health Status.
Baseline analyses and analyses after 12 months were conducted. Normal distribution is not given for SF-36 scales, means and Standard Deviation are reported. A high score defines a more favorable health state, items are scored on a 0 to 100 range. Scale scores represent the average for all items in the scale that the respondent answered.
12 months
Number of Inpatient Stays
12 months
Secondary Outcomes (8)
Number of Bed Days for Hospitalised Patients
12 months
Number of Primary Care Visits
12 months
Number of Specialist Visits
12 months
Number of Consultations of Emergency Doctor
12 months
All Cause Mortality
12 months
- +3 more secondary outcomes
Study Arms (3)
Control group
NO INTERVENTIONParticipants in the control group receive usual care.
Self monitoring for patients with COPD
EXPERIMENTALNurse monitoring for patients with COPD
EXPERIMENTALInterventions
Intervention Group entering vital parameters via Web Portal or automatic call center.
Nurses are entering vital parameters of the patient with mobile devices.
Eligibility Criteria
You may qualify if:
- COPD 3 or 4
- Be able to use the system provided
- Life expectancy \> 12 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Landeskrankenanstalten-Betriebsgesellschaftlead
- European Commissioncollaborator
Study Sites (3)
LKH Laas
Kötschach, Carintha, 9640, Austria
Klinikum Klagenfurt
Klagenfurt, Carinthia, 9020, Austria
LKH Villach
Villach, Carinthia, 9500, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Hannes Steinberger
- Organization
- Landeskrankenanstalten-Betriebsgesellschaft
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 17, 2012
First Posted
April 18, 2012
Study Start
February 1, 2010
Primary Completion
July 1, 2013
Study Completion
February 1, 2014
Last Updated
July 23, 2015
Results First Posted
July 1, 2015
Record last verified: 2015-04